Science 37 announced the opening of its new 19,000 sq. ft. headquarters in Research Triangle Park, NC. The new, state-of-the-art facility will enhance collaboration and improve patient recruitment and study support for clinical trials. 🔗 https://lnkd.in/eKpPAdx7 #clinicalresearch #clinicaltrials #clinicalstudies
Science 37
Research Services
Morrisville, North Carolina 25,635 followers
Access More Patients. Enroll Faster.
About us
Science 37’s mission is to accelerate clinical research by enabling universal trial access for patients. Through our solutions; the Metasite™ and Patient Recruitment, we accelerate enrollment by expanding the reach of clinical trials to patients beyond the traditional site and rigorously qualifying patients prior to referring them to a traditional site. Our solutions are powered by a proprietary technology stack with in-house medical and operational experts that enhance quality through standardized workflows and best-in-class study orchestration.
- Website
-
www.science37.com
External link for Science 37
- Industry
- Research Services
- Company size
- 501-1,000 employees
- Headquarters
- Morrisville, North Carolina
- Type
- Public Company
- Founded
- 2014
- Specialties
- Patient Recruitment, Patient Qualification, Clinical Trial Enrollment, Clinical Trial Access, Site Conduct, Virtual Site, Hybrid Clinical Trials, Remote Clinical Trials, Decentralized Clinical Trials, Clinical Trial Technology, and Real-World Evidence
Locations
-
Primary
Research Triangle Park
Morrisville, North Carolina, US
Employees at Science 37
Updates
-
🚗💡 Imagine being a clinical trial patient who has to travel over 60 miles each way to access potentially life-saving treatments. This is the reality for many participants. At Science 37, we bring the trial to the patient, reducing travel burdens and making participation easier and more accessible. Let's work together to create a future where distance is no longer a barrier to critical healthcare. Reach out to us to learn more: https://lnkd.in/e2v6DfFf
-
Our Chief Medical Officer Dr. Jonathan Cotliar recently joined the #DTRA Podcast for an episode on Science 37's successful FDA inspection. 🎧 Listen here: https://lnkd.in/eHBAHmik Decentralized Trials & Research Alliance (DTRA) #clinicalresearch #clinicaltrials #clinicalstudies
-
Science 37 reposted this
Is your #respiratory trial falling behind on enrollment? Science 37 can help you quickly find, recruit, and enroll patients for your study. In this recent trial, we delivered 28% of total randomized patients, 22x faster than other sites—wow! Contact us to learn more: https://lnkd.in/ex-zrTTs Lianne Marks MD PhD FACP #clinicalresearch #patientrecruitment #clinicaltrials
-
❗️ Low enrollment is a significant challenge in clinical trials, with 40% of sites struggling to meet enrollment targets and 11% failing to enroll any patients at all. This issue not only delays research progress but also increases costs and impacts the development of new treatments. But there's good news! Science 37 specializes in accelerating patient enrollment for both large and small-scale studies. 🌟 In every trial we've partnered on, we've successfully enrolled patients for our sponsors. And, in half of those trials, we've enrolled more patients than any other research site. Learn how we can help your study. Contact us now: https://lnkd.in/e2v6DfFf
-
Are you searching for ways to improve your clinical trials? Explore Science 37's library of Clinical Research Playbooks. Developed in collaboration with our internal Principal Investigators, these playbooks are designed to help researchers navigate the challenges of clinical trial access and enrollment. Explore our specialized playbooks for: 🩺 Oncology 🧠 Neurology 💭 Psychiatry 🫀 Cardiology 🫁 Respiratory 🥼 Dermatology 🦠 Infectious Disease…and more! Browse them all here: https://lnkd.in/eRPZmmef #clinicalresearch #clinicaltrials #clinicalstudies
-
In a recent trial, Science 37 successfully enrolled 42% of the study's immunocompromised cohort, averaging 65 randomized patients per month. "Depending on the rarity of the condition or sensitivities of the target patient population, some studies are inherently more difficult to recruit and enroll," said Dr. Debra Weinstein, VP of Internal Medicine and Principal Investigator at Science 37. “The complex nature of this study underscores Science 37’s ability to meet challenging clinical trial demands while enhancing patient access and care for vulnerable populations in a fully decentralized manner.” Read the press release: https://lnkd.in/ewCiWcJB #clinicalresearch #clinicaltrials #patientrecruitment #clinicalstudies #patientenrollment
-
-
We're #hiring! Apply today or share this post with your network.
-
Science 37 reposted this
Today, Science 37 disclosed the final figures resulting from its partnership with a biopharmaceutical company focused on infectious disease prevention research. Science 37 contributed to the recruitment and enrollment of an immunocompromised patient cohort for the sponsor’s Phase 3 trial. Leveraging its proprietary Virtual Site and Patient Recruitment solutions, Science 37 identified, recruited, medically qualified, and enrolled 129 patients across 36 states within an 8-week timeline, averaging 65 patients per month. Science 37 successfully randomized and treated 42% of the cohort while achieving significant geographic, socio-economic, and cultural diversity among participants, emerging as the top-enrolling site. Read the press release: https://lnkd.in/ewCiWcJB #clinicalresearch #clinicaltrials #patientrecruitment #clinicalstudies #patientenrollment
-
-
Today, Science 37 disclosed the final figures resulting from its partnership with a biopharmaceutical company focused on infectious disease prevention research. Science 37 contributed to the recruitment and enrollment of an immunocompromised patient cohort for the sponsor’s Phase 3 trial. Leveraging its proprietary Virtual Site and Patient Recruitment solutions, Science 37 identified, recruited, medically qualified, and enrolled 129 patients across 36 states within an 8-week timeline, averaging 65 patients per month. Science 37 successfully randomized and treated 42% of the cohort while achieving significant geographic, socio-economic, and cultural diversity among participants, emerging as the top-enrolling site. Read the press release: https://lnkd.in/ewCiWcJB #clinicalresearch #clinicaltrials #patientrecruitment #clinicalstudies #patientenrollment
-